Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease

Clinical Cancer Research

Volumn 6, Issue 2, 2000, Pages 566-571

  Wang, Li ^a   Friess, Helmut ^a   Zhu, Zhaowen ^a   Graber, Hans ^a   Zimmermann, Arthur ^b   Korc, Murray ^c   Reubi, Jean Claude ^a   Büchler, Markus W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NEUROTENSIN; NEUROTENSIN RECEPTOR;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; CANCER GRADING; CANCER STAGING; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PANCREAS CANCER; PANCREAS DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; RNA ANALYSIS; TUMOR DIFFERENTIATION;

ADULT; AGED; CHRONIC DISEASE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREAS; PANCREATIC DISEASES; PANCREATIC NEOPLASMS; RECEPTORS, NEUROTENSIN; REFERENCE VALUES; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0033956470     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA Cancer J. Clin., 65: 5-27, 1996.
2. Friess, H., Uhl, W., Beger, H. G., and Büchler, M. Surgical treatment of pancreatic cancer. Dig. Surg., 11: 378-386, 1994.
3. Korc, M., Chandrasekar, B., Yamanaka, Y., Friess, H., Büchler, M., and Beger, H. G. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increase in the levels of epidermal growth factor and transforming growth factor α. J. Clin. Invest., 90: 1352-1360, 1992.
4. Korc, M., Friess, H., Kobrin, M., Ebert, M., and Büchler, M. W. Growth factors in human pancreatic cancer: update on the role of the epidermal growth factor receptor. Dig. Surg., 11: 147-149, 1994.
5. Friess, H., Yamanaka, Y., Büchler, M., Ebert, M., Beger, H. G., Gold, L. I., and Korc, M. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology, 105: 1846-1856, 1993.
6. Lu, Z., Friess, H., Graber, H. U., Guo, X. Z., Schilling, M., Zimmermann, A., Korc, M., and Büchler, M. W. Presence of two signaling TGF-β receptors in human pancreatic cancer correlates with advanced tumor stage. Dig. Dis. Sci., 42: 2054-2063, 1997.
7. Carraway, R., and Leeman, S. E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalamic. J. Biol. Chem., 248: 6854-6861, 1973.
8. Reinecke, M. Neurotensin. Immunohistochemical localization in central and peripheral nervous system and in endocrine cells and its functional role as neurotransmitter and endocrine hormone. Prog. Histochem. Cytochem., 16: 1-172, 1985.
9. Nustede, R., Schmidt, W. E., Köhler, H., Fölsch, U. R., and Schafmayer, A. Role of neurotensin in the regulation of exocrine pancreatic secretion in dogs. Regul. Pept., 44: 25-32, 1993.
10. Sakamoto, T., Newman, J., Fujimura, M., Greeley, G. H., Townsend, C. M., and Thompson, J. C. Role of neurotensin in pancreatic secretion. Surgery, 96: 146-163, 1984.
11. Thor, K., and Rosell, S. Neurotensin increases colonic motility. Gastroenterology, 90: 27-31, 1986.
12. Andersson, S., Rosell, S., Hjelmquist, U., Chang, D., and Folkers, K. Inhibition of gastric and intestinal motor activity in dogs by {G1n4} neurotensin. Acta Physiol. Scand., 100: 231-235, 1977.
13. Sehgal, I., Powers, S., Huntley, B., Powis, G., Pittelkow, M., and Maihle, N. J. Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer. Proc. Natl. Acad. Sci. USA, 91: 4673-4677, 1994.
14. Sethi, T., Langdon, S., Smyth, J., and Rozengurt, E. Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Res., 52: 2737s-2742s, 1992.
15. Ishizuka, J., Townsend, C. M., and Thompson, J. C. Neurotensin regulates growth of human pancreatic cancer. Ann. Surg., 217: 439-446, 1993.
16. Yamada, M., Ohata, H., Momose, K., Yamada, M., and Richelson, E. Pharmacological characterization of SR 48692 sensitive neurotensin receptor in human pancreatic cancer cells, MIA PaCa-2. Res. Commun. Mol. Pathol. Pharmacol., 90: 37-47, 1995.
17. Iwase, K., Evers, B. M., Hellmich, M. R., Kim, H. J., Higashide, S., Gully, D., Thompson, J. C., and Townsend, C. M. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692. Cancer (Phila.), 79: 1787-1793, 1997.
18. Vita, N., Oury-Donat, F., Chalon, P., Guillemot, M., Kaghad, M., Bachy, A., Thurneyssen, O., Garcia, S., Poinot-Chazel, C., Casellas, P., Keane, P., Le Fur, G., Maffrand, J. P., Soubrie, P., Caput, D., and Ferrara, P. Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells. Eur. J Pharmacol., 360: 265-272, 1998.
19. Ovigne, J. M., Vermot-Desroches, C., Lecron, J. C., Portier, M., Lupker, J., Pecceu, F., and Wijdenes, J. An antagonistic monoclonal antibody (B-N6) specific for the human neurotensin receptor-1. Neuropeptides, 32: 247-256, 1998.
20. Le, F., Groshan, K., Zeng, X. P., and Richelson, E. Characterization of the genomic structure, promoter region, and a tetranucleotide repeat polymorphism of the human neurotensin receptor gene. J. Biochem., 272: 1315-1322, 1997.
21. Dubuc, I., Sarret, P., Labbe-Jullie, C., Botto, J. M., Honore, E., Bourdel, E., Martinez, J., Costentin, J., Vincent, J. P., Kitabgi, P., and Mazella, J. Identification of the receptor subtype involved in the analgesic effect of neurotensin. J. Neurosci., 19: 503-510, 1999.
22. Reubi, J. C., Waser, B., Friess, H., Büchler, M. W., and Laissae, J. Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma. Gut, 42: 546-550, 1998.
23. Sobin, L. H., and Wittekind, C. Pancreas. TNM classification of malignant tumors. In: Sobin, L. H., and Wittekind, C. (eds.), International Union Against Cancer (UICC), Ed. 5, pp. 87-90. New York: Wiley-Liss, Inc., 1997.
24. Chomczynski, P., Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
25. Friess, H., Lu, Z., Graber, H. U., Zimmermann, A., Adler, G., Korc, M., Schmid, R. M., and Büchler, M. W. bax, but not bcl-2, influences the prognosis of human pancreatic cancer. Gut, 43: 414-421, 1998.
26. di Mola, F. F., Friess, H., Scheuren, A., Di Sebastiano, P., Graber, H., Egger, B., Zimmermann, A., Korc, M., and Büchler, M. W. Transforming growth factor-βs and their signaling receptors are coexpressed in Crohn's disease. Ann. Surg., 229: 67-75, 1999.
27. Guo, X. Z., Friess, H., Di Mola, F. F., Heinicke, J. M., Abou-Shady, M., Graber, H. U., Baer, H. U., Zimmermann, A., Korc, M., and Büchler, M. W. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma. Hepatology, 28: 1481-1488, 1998.
28. Vita, N., Laurent, P., Lefort, S., Chalon, P., Dumont, X., Kaghad, M., Gully, D., Le Fur, G., Ferrara, P., and Caput, D. Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett., 317: 139-142, 1993.
29. Chalon, P., Vita, N., Kaghad, M., Guillemot, M., Bonnin, J., Delpech, B., Le Fur, G., Ferrara, P., and Caput, D. Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Lett., 386: 91-94, 1996.
30. Panoskaltsis-Mortari, A., and Bucy, R. P. In situ hybridization with digoxigenin-labeled RNA probes: facts and artifacts. BioTechniques, 18: 300-307, 1995.
31. Friess, H., Lu, Z., Andren-Sandberg, A., Berberat, P., Zimmermann, A., Adler, G., Schmid, R., and Büchler, M. W. Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer. Ann. Surg., 228: 780-787, 1998.
32. Meggiato, T., Ferrara, C., Tessari, G., Plebani, M., Paoli, M. D., Favero, G. D., and Naccarato, R. Serum neurotensin in human pancreatic cancer. Tumori, 82: 592-595, 1996.
33. Fisher, W. E., Doran, T. A., Muscarella, P., Boros, L. G., Ellison, E. C., and Schirmer, W. J. Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer. J. Natl. Cancer Inst., 90: 322-324, 1998.